EMS-Chemie Q1 2026 net sales fell 6.6% to CHF 487 million, driven by a 7.3 pp Swiss franc headwind despite higher volumes.
Operating income (EBIT) rose year‑on‑year, with both High Performance Polymers and Specialty Chemicals segments posting volume growth but currency‑driven sales declines.
Company prepared for US trade barriers by localising production or duty‑exempt classification, and warned of price hikes from energy and raw‑material costs.
Full‑year 2026 sales are expected below prior year due to currency effects, while EBIT is projected slightly above last year’s level.